Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Alzheimer's
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Alzheimer's
    TopAbstracts in Alzheimer's 05/15/2008 - (DGNews)
    Some NSAIDs May Not Improve Cognitive Function in Adults With Family History of Alzheimer's Disease - (DGNews)
    Switch From Donepezil Tablets to Rivastigmine Transdermal Patch Safe in Alzheimer's Disease: Presented at AGS - (DGDispatch)
    Tarenflurbil Elicits Sustained Responses in Treating Alzheimer's Disease: Presented at AGS - (DGDispatch)
    Ibuprofen May Reduce Risk of Alzheimer's Disease - (DGNews)

    News archive

     Recent webcasts/CME - Alzheimer's
    • Dementia in Hispanic Americans: The Reasons Behind the Risk
    • Modifiable Risk Factors Underlie Higher Dementia Rates in African Americans
    • Beliefs About Dementia Among Hispanics Impede Diagnosis and Treatment
    • Barriers to Diagnosis and Treatment of Dementia in African Americans Surmountable
    • New Perspectives on Common Clinical Conditions

      Webcasts/CME archive

       Recent cases - Alzheimer's
        Rapid Cognitive Improvement in Alzheimer's Disease Following Perispinal Etanercept Administration
        Advances in the Pharmacotherapy of Alzheimer's Disease
        Distinguishing Alzheimer's From Parkinson's
        Does He Have Alzheimer's Disease?

        Cases archive
          




        my personal edition > alzheimer's > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        High Oxidative Stress, Low Antioxidant Status In Alzheimer Disease

        A DGReview of :"Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease"
        Archives of Neurology

        06/03/2002
        By Anne MacLennan


        Markers of oxidative damage are increased in patients with Alzheimer disease (AD) and correlate with decreased levels of plasma antioxidants.

        In a study of 40 AD patients, lymphocyte content of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA, was significantly higher and plasma levels of antioxidants (except for lutein) significantly lower in patients than in healthy controls.

        Lymphocyte DNA 8-OHdG content in people AD may thus reflect a condition of increased oxidative stress related to a poor antioxidant status, these authors suggest.

        Patrizia Mecocci led this three-country project with colleagues from the Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy with contributors from the Institute of Physiological Chemistry, Heinrich-Heine University, Dusseldorf, Germany and Weill Medical College of Cornell University and the New York Hospital, Cornell Medical Center, New York.

        Although a large body of experimental evidence suggests oxidative stress plays a key role in AD pathogenesis, there have been few data on in vivo markers of free radical-induced damage.

        As well as evaluating levels of 8-OhdG in peripheral lymphocytes, these authors sought to measure plasma concentrations of several nonenzymatic antioxidants and to assess links between any observed changes in lymphocyte DNA 8-OHdG content and plasma antioxidant levels in these patients versus healthy controls.

        Study participants were the 40 AD patients and 39 healthy age- and sex-matched controls.

        As well as the higher lymphocyte DNA 8-OHdG content and lower plasma levels of antioxidants in these patients, researchers also noted a significant inverse relationship between lymphocyte DNA 8-OHdG content and plasma levels of lycopene, lutein, a-carotene and b-carotene, respectively.
        Arch Neurol. 2002;59:794-798. "Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send